prospective study for the correlation between urinary Dickkopf-3 and contrast induced nephropathy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025917

Enrollment

Unknown

Registered

2019-09-14

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast induced nephropathy

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Volunteered to participate in this trial and signed informed consent; 2. Aged more than 18 years; 3. Suspected as Coronary heart disease and Planned to execute Coronary angiography.

Exclusion criteria

Exclusion criteria: 1. Allergy to iodine or iodine contrast agent; 2. End-stage renal disease and kidney transplantation requiring peritoneal and hemodialysis; 3. Severe cardiac insufficiency and valvular heart disease, hemodynamic instability; 4. Definite bacterial and fungal infections, acute and chronic inflammatory diseases, autoimmune diseases, tumors, etc.; 5. Contrast agent was used within 2 weeks before admission; 6. Nephrotoxic drugs were used during hospitalization.

Design outcomes

Primary

Measure	Time frame
Primary Outcome Measures:The incedence of CIN;Dickkopf-3;	—

Countries

China

Contacts

Public ContactYan Gaoliang

Department of Cardiology, Zhongda Hospital of Southeast University Medical School

yan_seu@hotmail.com+86 18761890380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026